[Frequency of side-effects of tuberulostatics and its relation to the applied combination].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects*; D004357:Drug Synergism; D004361:Drug Tolerance; D005000:Ethionamide / Q000009:adverse effects; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D007612:Kanamycin / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D013307:Streptomycin / Q000009:adverse effects; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014756:Viomycin / Q000009:adverse effects
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007612:Kanamycin; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin
Die Häufigkeit der Nebenwirkungen der Tuberkulostatika und ihre Abhängigkeit von der angewandten Kombination.